The prognostic value of HER2 in ovarian cancer: A meta-analysis of observational studies.

Hui LuoXiaohui XuMiaomiao YeBo ShengXueqiong Zhu

Published in: PloS one (2018)

HER2 expression was related with poor prognosis in ovarian cancer patients and can be used as a predicting cancer prognostic biomarker in ovarian cancer patients.

Keyphrases

poor prognosis
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
long non coding rna
peritoneal dialysis
prognostic factors
squamous cell carcinoma
papillary thyroid
binding protein
patient reported
drug induced